Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPULSE-HF: CCM Therapy in Heart Failure
NCT02857309Terminated
- Sponsor
- Impulse Dynamics
- Start
- Feb 2014
- Primary completion
- Feb 2018
- Countries
- 4
01
Overview
Randomised, open-label trial (2 arms), sponsored by Impulse Dynamics. Primary endpoint: Change in Peak VO2 at 24 weeks. Started Feb 2014; status: terminated.
Beyond the preview
Go deeper on NCT02857309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02857309.